Which is better in patients with curatively resected extrahepatic biliary tract cancer? Adjuvant concurrent chemoradiation (CCRT) alone versus CCRT followed by maintenance chemotherapy

被引：0
|
作者：
Lim, K. [1 ]
Oh, D. [1 ]
Chie, E. [1 ]
Jang, J. [1 ]
Im, S. [1 ]
Kim, T. [1 ]
Kim, S. [1 ]
Ha, S. [1 ]
Bang, Y. [1 ]
机构：
[1] Seoul Natl Univ Hosp, Seoul 110744, South Korea
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2008年 / 26卷 / 15期
关键词：
D O I：
10.1200/jco.2008.26.15_suppl.15659
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
15659
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Comparison of outcomes for patients with unresectable, locally advanced non-small-cell lung cancer treated with induction chemotherapy followed by concurrent chemoradiation vs. concurrent chemoradiation alone
    Huang, Eugene H.
    Liao, Zhongxing
    Cox, James D.
    Guerrero, Thomas M.
    Chang, Joe Y.
    Jeter, Melinda
    Borghero, Yerko
    Wei, Xiong
    Fossella, Frank
    Herbst, Roy S.
    Blumenschein, George R., Jr.
    Moran, Cesar
    Allen, Pamela K.
    Komaki, Ritsuko
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2007, 68 (03): : 779 - 785
  • [32] Dose reduction to dysphagia/aspiration-related structures (DARS) in patients receiving induction chemotherapy (IC) followed by concurrent chemoradiation therapy (CCRT) for locally advanced squamous cell carcinoma of the head and neck (LASCCHN)
    Kann, Benjamin H.
    Carpenter, Todd J.
    Todorov, Blagoja
    Cotter, Ryan
    Golchin, Ava
    Bakst, Richard
    Misiukiewicz, Krzysztof
    Posner, Marshall
    Gupta, Vishal
    JOURNAL OF RADIATION ONCOLOGY, 2014, 3 (03) : 259 - 266
  • [33] A randomized, multi-center phase III trial of adjuvant chemotherapy with gemcitabine and capecitabine (GemCap) compared to capecitabine (Cap) alone in curatively resected biliary tract cancer (BilGemCap Study): KCSG HB20-14.
    Park, Joon Oh
    Park, Joon Seong
    Lee, Choong-kun
    Chon, Hong Jae
    Choi, Sae Byeol
    Hwang, Dae Wook
    Oh, Do-Youn
    Lee, Myung Ah
    Jang, Jin-Young
    Ryoo, Baek-Yeol
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 : TPS633 - TPS633
  • [34] A Randomized Phase II Trial of Adjuvant Chemotherapy With Uracil/Tegafur and Gemcitabine Versus Gemcitabine Alone in Patients With Resected Pancreatic Cancer
    Yoshitomi, Hideyuki
    Togawa, Akira
    Kimura, Fumio
    Ito, Hiroshi
    Shimizu, Hiroaki
    Yoshidome, Hiroyuki
    Otsuka, Masayuki
    Kato, Atsushi
    Nozawa, Satoshi
    Furukawa, Katsunori
    Miyazaki, Masaru
    CANCER, 2008, 113 (09) : 2448 - 2456
  • [35] Dysphagia and Dose Reduction to Dysphagia/Aspiration-Related Structures (DARS) in Patients Receiving Induction Chemotherapy (IC) Followed by Concurrent Chemoradiation Therapy (CCRT) for Locally-Advanced Squamous Cell Carcinoma of the Head and Neck (LASCCHN)
    Kann, B. H.
    Carpenter, T. J.
    Todorov, B.
    Golchin, A.
    Bakst, R.
    Misiukiewicz, K.
    Posner, M.
    Gupta, V.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2013, 87 (02): : S132 - S133
  • [36] Quality of life of locally advanced cervical cancer patients after neoadjuvant chemotherapy followed by chemoradiation versus chemoradiation alone (CIRCE trial): a randomized phase II trial
    de Arruda, Fernanda Nunes
    da Costa, Samantha
    Bonadio, Renata
    Dornellas, Abraao
    Pereira, Daniela
    de Bock, Geertruida H.
    Estevez Diz, Maria Del Pilar
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2020, 30 (06) : 749 - 756
  • [37] Feasibility and potential benefits of adjuvant chemotherapy with S-1 in patients with curative resected advanced biliary tract cancer: A multicenter trial.
    Toyoki, Yoshikazu
    Ishido, Keinosuke
    Kudo, Daisuke
    Kimura, Norihisa
    Wakiya, Taiichi
    Umehara, Yutaka
    Tohyama, Shigeru
    Endoh, Masaaki
    Tateoka, Hiroshi
    Ohishi, Susumu
    Hakamada, Kenichi
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [38] Phase II study of induction chemotherapy (ICT) with gemcitabine (G) and vinorelbine (V) followed by concurrent chemoradiation therapy (CCRT) with oral etoposide (E) and cisplatin (P) for inoperable stage IIIA/B non-small cell lung cancer (NSCLC).
    Lee, DH
    Han, JY
    Cho, KH
    Chun, JH
    Lee, HG
    Lee, JJ
    Pyo, HR
    Yoon, SJ
    Zo, JI
    Lee, JS
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 679S - 679S
  • [39] Comparison of Concurrent Chemoradiotherapy Followed by Adjuvant Chemotherapy Versus Concurrent Chemoradiotherapy Alone in Locoregionally Advanced Nasopharyngeal Carcinoma: a Meta-analysis of 793 Patients from 5 Randomized Controlled Trials
    Liang, Zhong-Guo
    Zhu, Xiao-Dong
    Zhou, Zhi-Rui
    Qu, Song
    Du, You-Qin
    Jiang, Yan-Ming
    ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 2012, 13 (11) : 5747 - 5752
  • [40] Effect of Adjuvant Chemotherapy with S-1 or Uracil-Tegafur compared to Surgery Alone for Patients Undergoing Curative Resection of Biliary Tract Cancer
    Itano, O.
    Shinoda, M.
    Kitago, M.
    Abe, Y.
    Hibi, T.
    Yagi, H.
    Ishii, M.
    Kitagawa, Y.
    ANNALS OF SURGICAL ONCOLOGY, 2014, 21 : S105 - S105
12345